Biomarkers in body fluids and their detection techniques for human intestinal permeability assessment.
Published In: Clinical Chemistry & Laboratory Medicine, 2025, v. 63, n. 11. P. 2115 1 of 3
Database: Academic Search Ultimate 2 of 3
Authored By: Zhang, Jian; Wang, Tianqi; Mao, Xuanjiao; Hu, Xinyu; Lv, Li; Qi, Haochen; Zheng, Lei 3 of 3
Abstract
Intestinal permeability (IP) is a crucial index for intestinal tract integrity, reflecting intestinal barrier function, injury, diseases, and related systemic conditions. However, current mainstream testing methods are invasive and qualitative. Biomarkers for IP in body fluids offer noninvasive and quantitative advantages for IP assessment while pose challenges for high-performance detection techniques. This review introduces the main types of biomarkers for IP, including sugar probes, endotoxin, D-lactic acid, intestinal fatty acid-binding protein, diamine oxidase, citrulline, zonulin and lipopolysaccharide-binding protein. Their sources, associated diseases and detection techniques are summarized, and the regulation of intestinal ecosystem and IP by diet are also briefly discussed. By investigating existing studies, various biomarkers in body fluids and their detection techniques are introduced, and the effectiveness and realizability of IP assessment with body fluid markers are demonstrated. This review can be as a reference for gastroenterologists, laboratory technicists and researchers. Body fluid biomarker detection provides a promising proach for IP in vitro assessment. To improve the feasibility in clinics, more types of biomarkers, more accurate physiological and pathological mechanisms, and more innovative sensing technologies are expected to be explored and developed. It is foreseeable that fast, precise, and on-site IP assessment will contribute to the clinical diagnosis and monitoring of intestinal and secondary diseases. [ABSTRACT FROM AUTHOR]
Additional Information
- Source:Clinical Chemistry & Laboratory Medicine. 2025/10, Vol. 63, Issue 11, p2115
- Document Type:Article
- Subject Area:Science
- Publication Date:2025
- ISSN:1434-6621
- DOI:10.1515/cclm-2025-0318
- Accession Number:188367642
- Copyright Statement:Copyright of Clinical Chemistry & Laboratory Medicine is the property of De Gruyter and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Looking to go deeper into this topic? Look for more articles on EBSCOhost.